Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
BackgroundMultiple sclerosis (MS) is a complex inflammatory disease in which demyelination occurs in the central nervous system affecting approximately 2.5 million people worldwide. Intestinal microbiome changes play an important role in the etiology of chronic diseases.ObjectiveThis study aimed to...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2022-09-01
|
| Collection: | Frontiers in Neuroscience |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fnins.2022.901846/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|